Prognostic  and predictive value of hematologic parameters in patients with metastatic renal  cell carcinoma: second line sunitinib treatment following IFN-alpha.

dc.contributor.authors	Dirican A, Kucukzeybek Y, Erten C, Somali I, Demir L, Can A, Payzin KB, Bayoglu IV, Akyol M, Yildiz Y, Koeseoglu M, Alacacioglu A, Tarhan MO
dc.date.accessioned	2020-02-27T08:36:05Z
dc.date.available	2020-02-27T08:36:05Z
dc.date.issued	2013
dc.identifier.citation	Dirican A, Kucukzeybek Y, Erten C, Somali I, Demir L, Can A, Payzin KB, Bayoglu IV, Akyol M, Yildiz Y, Koeseoglu M, Alacacioglu A, Tarhan MO (2013). Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alpha.. Asian Pac J Cancer Prev, 14(3), 5-2101
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66517
dc.title	Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alpha.
dc.identifier.volume	14(3)
dc.identifier.startpage	2101
dc.identifier.endpage	5
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Bayoğlu, İbrahim Vedat
dc.relation.journal	Asian Pac J Cancer Prev
dc.contributor.author	Bayoğlu, İbrahim Vedat